Bg pattern

BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Braquix 25 micrograms/125 micrograms/inhalation, suspension for inhalation in a pressurized container

Salmeterol/Fluticasone Propionate

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again. If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Braquix and what is it used for
  2. What you need to know before taking Braquix
  3. How to take Braquix
  4. Possible side effects
  5. Storage of Braquix
  6. Contents of the container and additional information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Braquix and what is it used for

Braquix contains two active substances: salmeterol and fluticasone propionate:

  • Salmeterol is a long-acting bronchodilator. Bronchodilators help keep the airways in the lungs open, making it easier to breathe in and out. The effects last for at least 12 hours.
  • Fluticasone propionate is a corticosteroid that reduces inflammation and irritation in the lungs.

Your doctor has prescribed this medication to help prevent respiratory problems such as asthma.

You should use Braquix every day, as your doctor has recommended. This will ensure that the medication works correctly to control your asthma.

Salmeterol/Fluticasone helps prevent shortness of breath and wheezing. However, Salmeterol/Fluticasone should not be used to relieve a sudden attack of shortness of breath or wheezing. If this happens, you should use your "rescue" medication of rapid action, such as salbutamol. You should always carry your rapid-acting rescue medication with you.

2. What you need to know before taking Braquix

Do not take Braquix:

  • If you are allergic to salmeterol, fluticasone propionate, or any of the other components of this medication (listed in section 6).
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Warnings and Precautions

Consult your doctor or pharmacist before taking Salmeterol/Fluticasone if you have:

  • Heart problems, including rapid or irregular heartbeat;
  • Hyperthyroidism;
  • High blood pressure;
  • Diabetes mellitus (Salmeterol/Fluticasone may increase your blood sugar levels);
  • Low potassium levels in the blood;
  • Tuberculosis (TB) currently or in the past, or other lung infections;

Contact your doctor if you experience blurred vision or other visual disturbances.

Other Medications and Braquix

Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication, including medications for asthma or any medication obtained without a prescription. This is because Salmeterol/Fluticasone may not be suitable to be taken with some other medications.

Tell your doctor if you are taking the following medications before starting to use Salmeterol/Fluticasone:

  • Beta-blockers (such as atenolol, propranolol, and sotalol). Beta-blockers are mainly used to treat high blood pressure or other heart conditions.
  • Medications to treat infections (such as ketoconazole, itraconazole, and erythromycin), including some medications for the treatment of HIV (such as ritonavir, products containing cobicistat). Some of these medications may increase the amount of fluticasone propionate or salmeterol in your body. This may increase your risk of experiencing side effects with this medication, including irregular heartbeats, or may worsen side effects. Therefore, your doctor may perform close monitoring if you are taking these medications.
  • Corticosteroids (oral or injectable). If you have taken these medications recently, this may increase the risk that this medication will affect your adrenal gland.
  • Diuretics, also known as water pills, used to treat high blood pressure.
  • Other bronchodilators (such as salbutamol).
  • Medications with xanthine. They are often used to treat asthma.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and Using Machines

Salmeterol/Fluticasone is unlikely to affect your ability to drive or use machines.

3. How to Use Braquix

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

  • Use Salmeterol/Fluticasone every day, until your doctor tells you to stop. Do not take more than the recommended dose. In case of doubt, consult your doctor or pharmacist.
  • Do not stop taking this medication or reduce the dose of Salmeterol/Fluticasone without talking to your doctor first.
  • Salmeterol/Fluticasone should be inhaled through the mouth into the lungs.
  • Use Salmeterol/Fluticasone always keeping track of the applications.
  • The inhaler has been designed to perform 120 applications.

However, it is not possible to know when the inhaler is empty and when the 120 applications have been released. It is possible that a small amount of liquid may still be left in the container.

Please make sure to replace your inhaler after releasing 120 applications so that you can be sure you are receiving the correct amount of your medication in each application.

Adults and Adolescents from 12 years old

  • Braquix 25/125 - 2 applications twice a day

Children from 4 to 12 years old

  • Braquix 25/50 - 2 applications twice a day
  • Braquix is not recommended for use in children under 4 years old.

Your symptoms may be well-controlled using Salmeterol/Fluticasone twice a day. If so, your doctor may decide to reduce your dose to once a day. The dose may change to:

  • once at night if you have nocturnalsymptoms.
  • once in the morning if you have diurnalsymptoms.

It is very important that you follow your doctor's instructions on how many applications and how often you should administer them.

If you are using this medication to treat asthma, your doctor will want to regularly monitor your symptoms.

If your asthma worsens or you have more difficulty breathing, see your doctor immediately.You may notice more wheezing or shortness of breath, chest tightness, or that you need to use your rapid-acting rescue medication more frequently. If any of these things happen to you, you should continue using Braquix, but do not increase the number of applications. Your respiratory disease may worsen and become seriously ill. See your doctor, as you may need additional treatment.

Instructions for Use

  • Your doctor, nurse, or pharmacist should teach you how to use the inhaler. Periodically, they should check how you use it. Not using the Braquix inhaler properly, or as prescribed, may result in your asthma not improving as it should.
  • The medication is in a pressurized cartridge inside a plastic casing with a mouthpiece.
  • A new, complete inhaler has enough medication for a minimum of 120 applications. After 120 applications, it is possible that the inhaler may no longer have enough medication to administer a full dose of medication.

Checking the Inhaler

  1. If you are using your inhaler for the first time, check that it works properly. Remove the mouthpiece cover by squeezing it gently on the sides with your thumb and index finger and pulling it off.
  2. To ensure the inhaler works, shake it well, direct the mouthpiece away from you, and press the cartridge to release an application into the air. Repeat these steps, shaking the inhaler before releasing a second application into the air. The total number of applications released into the air, before using the inhaler, should be two.
  3. After these first two test applications, you can start using your inhaler.
  4. If you have not used your inhaler for a week or more, or if your inhaler is very cold (below 0°C), release two applications of medication into the air.

Warnings

Never separate the metal cartridge from the inhaler.

Only if the inhaler becomes very cold (below 0°C), remove the metal cartridge from the plastic casing and warm it in your hands for a few minutes before using it. Never use anything else to warm it. Once warmed and before using it, press the cartridge firmly to release two applications into the air.

Using the Inhaler

It is essential to start inhaling as slowly as possible just before using your inhaler.

Hand holding an auto-injector with an arrow indicating pressure on the activation buttonHand holding an applicator device with a needle inserted into the skin, showing arrows indicating direction of movementPatient sitting with leg raised and an injection being applied to the thigh with a syringeHand holding an applicator device with a needle inserted into the skin, arrows indicate direction and movement of the applicatorHand holding an auto-injector with a black protective cover and an arrow indicating direction of injection into the skin

  1. It is recommended that you stand or sit upright while using the inhaler.
  2. Remove the mouthpiece cover (Figure A).
  3. Check inside and outside that the mouthpiece is clean and free of dust or any foreign particles.
  4. Shake the inhaler 4 or 5 times to ensure the contents of the inhaler mix evenly (Figure B).
  5. Hold the inhaler in a vertical position with your thumb on the base of the inhaler, below the mouthpiece. Expel as much air as possible (Figure C).
  6. Place the mouthpiece in your mouth, between your teeth. Close your lips around the mouthpiece. Do not bite it.
  7. Take air in through your mouth slowly and deeply. Immediately after starting to breathe in, press the top of the inhaler firmly to release an application of the medication. Do this while continuing to breathe in deeply and steadily (Figure D).
  8. Hold your breath, remove the inhaler from your mouth, and your finger from the top of the inhaler. Continue holding your breath for a few seconds, as long as you can.
  9. Wait approximately half a minute between each application of the medication and then repeat steps 4 to 8.
  10. Afterward, rinse your mouth with water and spit it out and/or brush your teeth. This will help prevent the appearance of mouth sores and hoarseness.
  11. After using it, always put the mouthpiece cover back on immediately to preserve it from dust (Figure E). When the mouthpiece cover is placed correctly, it will make a "click". Do not use excessive force.

Take your time in steps 5, 6, 7, and 8. It is essential that just before using the inhaler, you inhale as slowly as possible. The first few times you use the inhaler, you should use it in front of a mirror. If you see "mist" coming out of the top of the inhaler or from the sides of your mouth, you should start again from step 4.

As with all inhalers, caregivers should ensure that children using Salmeterol/Fluticasone use the correct inhalation technique described above.

If you or your child find it difficult to use the inhaler, your doctor, nurse, or pharmacist may recommend using a spacer device, AeroChamber Plus®, with your inhaler. Your doctor, nurse, pharmacist, or other healthcare professional should show you how to use the spacer device with your inhaler and how to maintain your spacer device, and answer any questions you may have. If you are using the spacer device with your inhaler, it is essential that you do not stop using it without consulting your doctor or nurse first. It is not recommended to use other spacer devices with Braquix, and you should not switch from the AeroChamber Plus® to another.It is also essential that you do not change or stop using the spacer without consulting your doctor; he will know how to modify the therapy. Always consult your doctor before making any changes to your asthma treatment.

Some children or people with little hand strength may find it easier to hold the inhaler with both hands. Place your two index fingers on the top of the inhaler and both thumbs on the base, below the mouthpiece.

Cleaning the Inhaler

To prevent your inhaler from becoming blocked, it is essential to clean it at least once a week.

To clean your inhaler:

  • Remove the mouthpiece cover.
  • Never remove the metal cartridge from the plastic casing.
  • Clean the inside and outside of the mouthpiece and the plastic casing with a dry cloth or a paper towel.
  • Put the mouthpiece cover back on. It will make a "click" when it is placed correctly.
  • Do not use excessive force.
  • Do not put the metal cartridge in water.

If you use more Braquix than you should

It is essential to use the inhaler as indicated. If you accidentally take a higher dose than recommended, consult your doctor or pharmacist. You may notice that your heart beats faster than normal, and you may feel tremors. You may also experience headache, dizziness, weakness, and joint pain.

If you have used high doses for extended periods, you should ask your doctor or pharmacist for advice. This is because high concentrations of Salmeterol/Fluticasone may reduce the amount of steroid hormones produced by the adrenal gland.

In case of overdose or accidental ingestion, consult your doctor or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Braquix

Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.

If you interrupt treatment with Braquix

It is very important that you take your Salmeterol/Fluticasone every day as indicated. Continue taking it until your doctor tells you to stop. Do not interrupt or suddenly reduce your treatment with Salmeterol/Fluticasone. This could make your breathing worsen.

Additionally, if you suddenly stop taking this medication or reduce your dose of Salmeterol/Fluticasone, you may (very rarely) experience problems with your adrenal gland (adrenal insufficiency), which sometimes causes side effects.

These side effects may include any of the following:

  • Stomach pain
  • Fatigue and loss of appetite, feeling unwell
  • Nausea and diarrhea
  • Weight loss
  • Headache or drowsiness
  • Low blood sugar levels
  • Low blood pressure and convulsions (seizures)

When your body is under stress, such as fever, trauma (such as a car accident), infection, or surgery, adrenal insufficiency may worsen, and you may experience any of the above side effects.

If you experience any side effect, consult your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe an additional dose of oral corticosteroids (such as prednisolone).

If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.

4. Possible Side Effects

Like all medications, this medication may cause side effects, although not everyone experiences them. To reduce the possibility of side effects, your doctor will prescribe the lowest dose of Salmeterol/Fluticasone to control your asthma.

Allergic Reactions: you may notice that your breathing suddenly worsens immediately after using Salmeterol/Fluticasone

The following are other side effects:

Very Common (may affect more than 1 in 10 people)

  • Headache: usually improves with treatment.
  • A increase in the number of colds has been reported in patients with COPD.

Common (may affect up to 1 in 10 people)

  • Thrush (painful, creamy white, raised patches in the mouth and throat). Also, pain in the tongue and hoarse voice and throat irritation. Rinsing your mouth with water and spitting it out and/or brushing your teeth immediately after each dose of medication may help. For the treatment of thrush, your doctor may prescribe antifungal medication.
  • Pain and inflammation of the joints and muscle pain.
  • Muscle cramps.

The following side effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):

  • Pneumonia and bronchitis (lung infection). Tell your doctor if you notice any of the following symptoms: increased production of sputum, change in the color of sputum, fever, chills, increased cough, increased difficulty breathing.
  • Bruises and fractures.
  • Sinusitis (feeling of tension or fullness in the nose, cheeks, and behind the eyes, sometimes with a pulsating pain).
  • Low potassium levels in the blood (you may feel irregular heartbeats, muscle weakness, cramps).

Uncommon (may affect up to 1 in 100 people)

  • Increased amount of sugar (glucose) in the blood (hyperglycemia). If you have diabetes, you will need to check your blood sugar levels more frequently and adjust your usual diabetic treatment if necessary.
  • Cataracts (opacity of the eye lens).
  • Very fast heart rate (tachycardia).
  • Feeling of tremors and a fast or irregular heart rate (palpitations). These adverse effects are usually harmless and decrease when treatment is continued.
  • Chest pain.
  • Feeling of concern (occurs mainly in children).
  • Sleep disorders.
  • Allergic skin rash.

Rare (may affect up to 1 in 1,000 people)

  • Breathing difficulties or wheezing that worsen immediately after using salmeterol/fluticasone.If this happens, stop using this medication. Use your rapid-acting "rescue" inhaler to improve your breathing and inform your doctor immediately.
  • Salmeterol/fluticasone may increase the normal production of steroid hormones, particularly if you have been taking high doses for long periods of time.

The effects include:

  • Slowing of growth in children and adolescents
  • Decrease in bone mineral density
  • Glaucoma
  • Weight gain
  • Rounded face (moon face) (Cushing's syndrome)

Your doctor will regularly monitor any of these adverse effects and ensure that you are taking the lowest dose of salmeterol/fluticasone to control your asthma.

  • Changes in behavior, such as hyperactivity and irritability (these effects occur mainly in children).
  • Irregular heartbeats or extra heartbeats (arrhythmias). Consult your doctor, but do not stop taking salmeterol/fluticasone unless your doctor tells you to do so.
  • Fungal infection in the esophagus (throat), which can cause difficulty swallowing.

Frequency not known (frequency cannot be estimated from available data):

  • Depression or aggression. These effects are more likely in children.
  • Blurred vision

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Braquix

Keep this medication out of sight and reach of children.

Do not use Braquix after the expiration date shown on the label and on the carton after CAD. The expiration date is the last day of the month indicated.

Do not store at a temperature above 25°C.

The cartridge contains a pressurized liquid. Do not expose it to temperatures above 50°C, protect it from direct sunlight. Do not puncture, break, or burn the cartridge even if it is empty.

Do not use this medication if you notice visible signs of deterioration.

As with most medications administered by inhalation in pressurized cartridges, the therapeutic effect may decrease if the cartridge is cooled.

Medicines should not be thrown down the drain or into the trash. Deposit the containers and medications you no longer need at the Sigre Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This way, you will help protect the environment.

6. Appearance of the product and package contents

Composition of Braquix

The active ingredients are salmeterol and fluticasone propionate. Each pressurized dose contains 25 micrograms of salmeterol (as salmeterol xinafoate) and 125 micrograms of fluticasone propionate.

The other ingredient is the propellant: norflurane (HFA 134a).

Appearance of the product and package contents

  • Braquix is presented in a pressurized container with a counter, which releases the medication in the form of a suspension for inhalation through the mouth into the lungs.
  • The pressurized cartridge contains a homogeneous white inhalation suspension.
  • The cartridge is located inside a plastic device that incorporates a mouthpiece and a dust protector of purple color.
  • Each carton contains 1 inhaler. Each inhaler contains 120 applications.

Marketing authorization holder

MABO-FARMA, S.A.

Vía de los Poblados 3, Edificio 6,

28033 Madrid,

Spain.

Manufacturer

GENETIC, S.P.A.

Contrada Canfora

Fisciano, Salerno

84084 Italy

This medication is authorized in the member states of the European Economic Area under the following names:

Country

Medication name

Portugal:

Flusonide

Spain:

Braquix 25 micrograms/125 micrograms/inhalation, inhalation suspension in pressurized container.

Date of the last revision of this leaflet:09/2021

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension

Discuss questions about BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension?
BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension?
The active ingredient in BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension is salmeterol and fluticasone. This information helps identify medicines with the same composition but different brand names.
Who manufactures BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension?
BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension is manufactured by Mabo Farma S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BRAQUIX 25/125 micrograms/inhalation, pressurized inhalation suspension?
Other medicines with the same active substance (salmeterol and fluticasone) include AIRFLUSAL FORSPIRO 50 micrograms/250 micrograms inhalation powder (single dose), AIRFLUSAL FORSPIRO 50 micrograms/500 micrograms inhalation powder (single dose), AMAIRA 50 micrograms/100 micrograms Inhalation Powder (single dose). These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media